Jun Ling Lu

Suggest Changes
Learn More
BACKGROUND The efficacy of 25-hydroxyvitamin D (25[OH]D) supplementation versus vitamin D receptor activators for the treatment of secondary hyperparathyroidism (SHPT) in patients with chronic kidney(More)